Genetic comparisons between variant H3N2 (H3N2v) influenza viruses collected from swine at Ohio fairs in 2012 and those collected from case-patients from a large outbreak that year showed an almost 100% match, according to a study today in Emerging Infectious Diseases.
Officials from the US Centers for Disease Control and Prevention (CDC) said yesterday that it might be impossible to trace how H9N2 avian flu samples it sent to a US Department of Agriculture (USDA) lab in Athens, Ga., became cross-contaminated with the lethal H5N1 strain, Reuters reported yesterday.
The European Centre for Disease Prevention and Control (ECDC) said this week that the safety of gain-of-function (GOF) studies like a recent one involving the generation of a 1918-like influenza virus merits more public discussion, given the obligation of researchers to "first do no harm."
The hearing revealed systemic problems and worries about the safety culture of lab workers.
H7N9 found after poultry markets reopened in China in 2013
In addition to recent problems with anthrax and smallpox, high-path avian flu has now entered the mix.
Phase 3 clinical trial results for the most advanced dengue vaccine in development, known as CYD-TDV and made by Sanofi Pasteur, showed it is more than 50% protective overall and nearly 90% effective against the most serious, hemorrhagic form of the disease, according to a new study published in The Lancet.
A 34-year-old Egyptian man whose H5N1 avian flu case was announced in late June has died, the World Health Organization (WHO) said yesterday in a statement.
The latest pattern in West Africa's Ebola virus disease (EVD) outbreak suggests a "mixed picture," with Guinea showing a drop-off in infections, but Sierra Leone and Liberia reporting several new cases, the World Health Organization (WHO) said today in its latest update.
UW calls a recent UK newspaper story biased and largely wrong.
